ArticleNPJ precision oncology2025
Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures.
Tingting Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it